Has the adipokine profile an influence on the catch-up growth type in small for gestational age infants?

Léniz, Asier; Portillo, Marı́a P.; Fernández‐Quintela, Alfredo; Macarulla, M. T.; Sarasua-Miranda, Ainhoa; Hoyo, Marta Del; Díez-López, Ignacio

doi:10.1007/s13105-019-00684-6

Cited by 4 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, the analysis of chemerin concentrations in discordant twins revealed that neonates with SGA (small for gestational age) had significantly lower chemerin cord levels than their siblings [202]. The follow-up study performed on the group of SGA newborns demonstrated that newborns with slow catch-up growth had significantly higher chemerin levels, measured at 3 months of age, compared with those with normal catch-up growth [204].…”

Section: Other Gestational Complicationsmentioning

confidence: 99%

The Role of the Adipokines in the Most Common Gestational Complications

Gutaj

Sibiak

Jankowski

et al. 2020

IJMS

View full text Add to dashboard Cite

Adipocytokines are hormonally active molecules that are believed to play a key role in the regulation of crucial biological processes in the human body. Numerous experimental studies established significant alterations in the adipokine secretion patterns throughout pregnancy. The exact etiology of various gestational complications, such as gestational diabetes, preeclampsia, and fetal growth abnormalities, needs to be fully elucidated. The discovery of adipokines raised questions about their potential contribution to the molecular pathophysiology of those diseases. Multiple studies analyzed their local mRNA expression and circulating protein levels. However, most studies report conflicting results. Several adipokines such as leptin, resistin, irisin, apelin, chemerin, and omentin were proposed as potential novel early markers of heterogeneous gestational complications. The inclusion of the adipokines in the standard predictive multifactorial models could improve their prognostic values. Nonetheless, their independent diagnostic value is mostly insufficient to be implemented into standard clinical practice. Routine assessments of adipokine levels during pregnancy are not recommended in the management of both normal and complicated pregnancies. Based on the animal models (e.g., apelin and its receptors in the rodent preeclampsia models), future implementation of adipokines and their receptors as new therapeutic targets appears promising but requires further validation in humans.

show abstract

Section: Other Gestational Complicationsmentioning

confidence: 99%